To obtain an adequate cervical smear for making a correct cytologic diagnos
is, smear taking, laboratory handling and interpretation must be optimal. M
any people are involved, and only by combined effort of all links can this
target be seriously approached: the smear takers will have to be open minde
d about technical improvements and read the morphologic descriptions cautio
usly; in the laboratory, cytotechnicians and physicians will have to challe
nge themselves and each other. It is mandatory to discard specimens that do
not meet general standards of adequacy. At present a host of new technique
s are being implemented. It is not feasible for all laboratories to be enga
ged in testing these ne iu methods, but we are all requested to follow the
development the best we can and switch to new ways when justified. Our work
ing conditions are very different; therefore, it is our professional respon
sibility and plight to respond at the right time. So far the conclusion is
that the conventional Pap smear is the international standard of care for t
he diagnosis of cervical cancer precursers in cancer screening programs. Ce
rtainly, this may change within a very short time. Liquid-based techniques,
and in particular HPV technologies, are just around the corner.